First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites.
Poinsignon A, Samb B, Doucoure S, Drame PM, Sarr JB, Sow C, Cornelie S, Maiga S, Thiam C, Rogerie F, Guindo S, Hermann E, Simondon F, Dia I, Riveau G, Konate L, Remoue F.
Poinsignon A, et al. Among authors: remoue f.
Trop Med Int Health. 2010 Oct;15(10):1198-203. doi: 10.1111/j.1365-3156.2010.02611.x. Epub 2010 Aug 17.
Trop Med Int Health. 2010.
PMID: 20723184
Free article.